Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis

European Archives of Oto-Rhino-Laryngology

Volumn 267, Issue 2, 2010, Pages 245-250

  Pfaar, Oliver ^a,c   Mösges, Ralph ^b   Hörmann, Karl ^a   Klimek, Ludger ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Center for Rhinology and Allergology   (Germany)

Author keywords

Allergic rhinoconjunctivitis; Cluster immunotherapy; Specific immunotherapy (SIT); Specific subcutaneous immunotherapy (SCIT)

Indexed keywords

ALLERGEN; ALUTARD; ALUTARD SQ; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANAPHYLACTIC SHOCK; ARTICLE; BLOOD PRESSURE FLUCTUATION; BRONCHOSPASM; CLINICAL TRIAL; CLUSTER SPECIFIC IMMUNOTHERAPY; CONJUNCTIVITIS; CONSCIOUSNESS DISORDER; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; HAY FEVER; HEADACHE; HEART ARREST; HUMAN; HYPOTENSION; IMMUNOTHERAPY; INJECTION SITE REACTION; INJECTION SITE SWELLING; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MICTURITION; MULTIPLE ORGAN FAILURE; PALLOR; PRIORITY JOURNAL; PRURITUS; PULSE RATE; RESPIRATORY ARREST; RESTLESSNESS; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; URTICARIA;

ADOLESCENT; ADULT; ANTIGENS, PLANT; CONJUNCTIVITIS, ALLERGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; POLLEN; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73649084776     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-009-1077-6     Document Type: Article

References (29)

1. J Bousquet N Khaltaev AA Cruz, et al. 2008 Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy 63 Suppl 86 8 160 10.1111/j.1398-9995.2007.01620.x 18331513 (Pubitemid 351357811)
2. E Compalati M Penagos F Tarantini G Passalacqua GW Canonica 2009 Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses Ann Allergy Asthma Immunol 102 22 28 19205281
3. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S (2007) Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev CD001936
4. L Jacobsen B Niggemann S Dreborg HA Ferdousi S Halken A Host A Koivikko LA Norberg E Valovirta U Wahn C Moller 2007 Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study Allergy 62 943 948 10.1111/j.1398-9995.2007.01451.x 1:STN:280:DC%2BD2svgt1Cqug%3D%3D 17620073 (Pubitemid 47037870)
5. F Purello-D'Ambrosio S Gangemi RA Merendino S Isola P Puccinelli S Parmiani L Ricciardi 2001 Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study Clin Exp Allergy 31 1295 1302 10.1046/j.1365-2222.2001.01027.x 11529901 (Pubitemid 34208970)
6. PA Eng M Borer-Reinhold IA Heijnen HP Gnehm 2006 Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood Allergy 61 198 201 10.1111/j.1398-9995.2006.01011.x 1:STN:280: DC%2BD28%2Fit1Smtg%3D%3D 16409196 (Pubitemid 43381830)
7. U Lüderitz-Püchel B Keller-Stanislawski D Haustein 2001 Risk reevaluation, diagnostic and therapeutic allergen extracts. An analysis of adverse drug reactions from 1991 to 2000 Bundesgesundheitsbl-Gesundheitsforsch Gesundheitsschutz 44 709 718 10.1007/s001030100201
8. J Kleine-Tebbe KC Bergmann F Friedrichs, et al. 2006 Specific immunotherapy (hyposensitization) for IgE mediated allergic diseases Allergo J 15 56 74
9. O Pfaar L Klimek 2008 Specific immunotherapy for allergic rhinitis. Current methods and innovative developments HNO 56 764 775 10.1007/s00106-008- 1732-z 1:STN:280:DC%2BD1crgtF2qsA%3D%3D 18668217
10. L Cox 2006 Accelerated immunotherapy schedules: review of efficacy and safety Ann Allergy Asthma Immunol 97 126 137 1:CAS:528:DC%2BD28XpsFGgsb4%3D 16937741
11. L Klimek H Wolf T Mewes D Dormann A Reske-Kunz J Schnitker W Mann 1999 The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions J Allergy Clin Immunol 103 47 53 10.1016/S0091-6749(99)70524-5 1:CAS:528:DyaK1MXhtVymtLo%3D 9893184 (Pubitemid 29063190)
12. O Pfaar L Klimek 2009 Cluster immunotherapy in allergic rhinoconjunctivitis. A review on new therapeutic approaches Atemwegs und Lungenerkrankungen 35 223 228
13. H Malling B Weeke 1993 Position paper: immunotherapy. (EAACI) The European Academy of Allergology and Clinical Immunology Allergy 48 7 35
14. I Hansen BA Stuck S Schneider-Gene R Mösges K Hörmann L Klimek 2002 Cluster specific immunotherapy in allergic rhinoconjunctivitis: current standard and new approaches Allergologie 25 549 556
15. E Alvarez-Cuesta J Bousquet GW Canonica SR Durham HJ Malling E Valovirta 2006 Standards for practical allergen-specific immunotherapy Allergy 61 Suppl 82 1 20 10.1111/j.1398-9995.2006.01219-1.x 16930249 (Pubitemid 44366956)
16. R Ariano P Berto D Tracci C Incorvaia F Frati 2006 Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma Allergy Asthma Proc 27 159 163 16724637
17. C Incorvaia F Agostinis S Amoroso, et al. 2007 Pharmacoeconomics of subcutaneous allergen immunotherapy Eur Ann Allergy Clin Immunol 39 17 20 18924462
18. J Bousquet RF Lockey HJ Malling 1998 WHO position paper: allergen immunotherapy: therapeutic vaccines for allergic diseases Allergy 53 1 42 (Pubitemid 28346358)
19. PS Norman LM Lichtenstein DG Marsh 1981 Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever J Allergy Clin Immunol 68 460 470 10.1016/0091-6749(81)90200-1 1:STN:280:DyaL38%2Fns1eqsg%3D%3D 7031112
20. J Subiza A Feliu JL Subiza J Uhlig E Fernandez-Caldas 2008 Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment Clin Exp Allergy 38 987 994 10.1111/j.1365-2222.2008.02995.x 1:STN:280:DC%2BD1czjtlOktg%3D%3D 18445082 (Pubitemid 351725861)
21. C Colas S Monzon M Venturini A Lezaun 2006 Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule J Allergy Clin Immunol 117 810 816 10.1016/j.jaci.2005.11.039 1:CAS:528:DC%2BD28XjslelsL8%3D 16630938 (Pubitemid 44313815)
22. M Mauro M Russello R Alesina V Sillano A Alessandrini A Dama G Passalacqua G Senna 2006 Safety and pharmacoeconomics of a cluster administration of mite immunotherapy compared to the traditional one Eur Ann Allergy Clin Immunol 38 31 34 16544586
23. AI Tabar S Echechipia BE Garcia JM Olaguibel MT Lizaso B Gomez MT Aldunate S Martin F Marcotegui 2005 Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus J Allergy Clin Immunol 116 109 118 10.1016/j.jaci.2005.05.005 15990782 (Pubitemid 40909756)
24. C Moreno L Fernandez-Tavora S Acero, et al. 2003 Tolerance of a cluster schedule on the treatment of seasonal allergic respiratory disease with pollen extracts quantified in mass units J Investig Allergol Clin Immunol 13 221 227 1:STN:280:DC%2BD2c%2FpvFKltg%3D%3D 14989109
25. MT Mellerup GW Hahn LK Poulsen H Malling 2000 Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment Clin Exp Allergy 30 1423 1429 10.1046/j.1365-2222.2000.00910.x 1:STN:280:DC%2BD3M%2FhvF2lsA%3D%3D 10998019 (Pubitemid 30765651)
26. SM Walker GB Pajno MT Lima DR Wilson SR Durham 2001 Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial J Allergy Clin Immunol 107 87 93 10.1067/mai.2001.112027 1:STN:280: DC%2BD3M7gslyitQ%3D%3D 11149996 (Pubitemid 32105250)
27. O Pfaar L Klimek I Fischer J Sieber S Amoroso AC Moreno K Shah R Mosges 2009 Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens Int Arch Allergy Immunol 150 102 108 10.1159/000210436 1:STN:280:DC%2BD1MrlvV2htw%3D%3D 19339808
28. Pfaar O, Mosges R, Hormann K, Klimek L (2009) Cluster immunotherapy of persistent allergic rhinoconjunctivitis: safety aspects of induction therapy with mite depot allergen preparations. HNO (Epub ahead of print)
29. I Hansen K Hormann BA Stuck S Schneider-Gene R Mosges L Klimek 2003 Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal) Laryngorhinootologie 82 558 563 10.1055/s-2003-41234 1:STN:280:DC%2BD3sznvF2hsA%3D%3D 12915987 (Pubitemid 37055560)